Skip to main content
Clinical Trials/NCT04265807
NCT04265807
Completed
Not Applicable

Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot

University of Washington1 site in 1 country30 target enrollmentJuly 1, 2020
ConditionsCardiac Arrest

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Arrest
Sponsor
University of Washington
Enrollment
30
Locations
1
Primary Endpoint
Attrition
Status
Completed
Last Updated
last year

Overview

Brief Summary

Following resuscitation from out-of-hospital cardiac arrest (OHCA), reperfusion injury can cause cell damage in the heart and brain. Remote ischemic conditioning (RIC) consists of intermittent application of a device such as a blood pressure cuff to a limb to induce non-lethal ischemia. Studies in animals with cardiac arrest as well as in humans with acute myocardial infarction suggest that RIC before or after restoration of blood flow may reduce injury to the heart and improve outcomes but this has not been proven in humans who have had OHCA. The RICE pilot study is a single-center study to assess the feasibility of application of RIC in the emergency department setting for patients transported to the hospital after resuscitation from OHCA.

Registry
clinicaltrials.gov
Start Date
July 1, 2020
End Date
February 3, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Graham Nichol

Professor, School of Medicine: Department of Medicine: General Internal Medicine

University of Washington

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Attrition

Time Frame: Completion of their allocated study intervention, an average of 30 minutes from enrollment

Attrition assessed as the proportion of randomized subjects who do not remain on allocated therapy for the intended study duration among subjects randomly allocated. On therapy for the intended study duration consists of completing three cycles of inflation-deflation.

Secondary Outcomes

  • Treatment Success(30 minutes from initiation of study intervention)
  • Cardiac Function(Within 48 hours of index arrest)
  • Proportion With Cardiogenic Shock, %(Within 48 hours of index arrest)
  • STEMI(Within 48 hours of index arrest)
  • Myocardial Injury(Within 24 hours of index arrest)
  • Renal Dysfunction(Within 24 hours of index arrest)
  • Hospital Free Survival(Within 30 days of index arrest)
  • Withdrawal of Care(Discharge or 30 days after index arrest)
  • Favourable Neurologic Status at Discharge(Discharge or 30 days after index arrest)
  • Survival to Discharge(Discharge or 30 days after index arrest)
  • Clinical Instability at Discharge(Discharge or 30 days after index arrest)
  • Survival to 30 Days After Arrest(30 days after index arrest)
  • Accrual(Before leaving the emergency department)

Study Sites (1)

Loading locations...

Similar Trials